दावा इनकार प्रबंधन में देरी
Definition
Denied claims require manual root cause analysis, corrections, and appeals, leading to extended A/R cycles and cash flow delays specific to healthcare RCM in India.
Key Findings
- Financial Impact: ₹10-20 lakhs/month in delayed reimbursements; 30-45 days A/R extension per unresolved claim
- Frequency: Ongoing per denied claim (common 20-30% denial rates)
- Root Cause: Manual handling of denials due to coding errors, documentation gaps, and payer-specific rules
Why This Matters
The Pitch: Medical and Diagnostic Laboratories in India 🇮🇳 face 30%+ denial rates wasting ₹10-20 lakhs/month in delayed collections. Automation of denial analysis and appeals eliminates this Time-to-Cash drag.
Affected Stakeholders
Billing Manager, Revenue Cycle Team, AR Specialist
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
अपील विफलता से राजस्व हानि
इनकार अपील पर कर्मचारी क्षमता हानि
अनबिल्ड लैब सर्विसेज
फर्जी रिपोर्ट फाइन
ओवरचार्जिंग पेनल्टी
रिक्विजिशन मैनुअल डिले से आइडल इक्विपमेंट
Request Deep Analysis
🇮🇳 Be first to access this market's intelligence